Centessa Pharmaceuticals plc (CNTA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 15M | 0 | 0 | 0 | 0 | 6.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | -100% | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 238.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -238.6K | 0 | 0 | 0 | 15M | 0 | 0 | 0 | 0 | 6.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | 100% | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -101.59% | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 79.77M | 68.47M | 53.79M | 54.65M | 45.78M | 74.58M | 46.41M | 43.98M | 36.09M | 42.03M | 40.21M | 47.02M | 48.88M | 41.6M | 49.03M | 68.41M | 53.22M | 0 | 38.31M | 41.29M |
| OpEx % of Revenue | - | - | - | - | 305.18% | - | - | - | - | 613.32% | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 19.88M | 13.99M | 12.23M | 11.91M | 12.33M | 13.71M | 12.5M | 11.16M | 13.44M | 12.31M | 12.02M | 13.35M | 16.05M | 13.77M | 12.28M | 14.76M | 14.38M | 0 | 12.46M | 11.84M |
| SG&A % of Revenue | - | - | - | - | 82.23% | - | - | - | - | 179.7% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 59.89M | 54.48M | 41.56M | 42.74M | 33.44M | 60.87M | 33.9M | 32.81M | 22.65M | 29.72M | 28.19M | 33.67M | 32.83M | 27.84M | 36.74M | 53.65M | 36.85M | 0 | 25.85M | 18.13M |
| R&D % of Revenue | - | - | - | - | 222.95% | - | - | - | - | 433.62% | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 1000K |
| Operating Income | -79.77M | -68.47M | -53.79M | -54.65M | -30.78M | -74.58M | -46.41M | -43.98M | -36.09M | -35.18M | -40.21M | -47.02M | -48.88M | -41.6M | -49.03M | -68.41M | -53.22M | 0 | -38.31M | -41.29M |
| Operating Margin % | - | - | - | - | -205.18% | - | - | - | - | -513.32% | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -159.2% | 8.19% | -15.91% | -24.27% | 14.72% | -112.01% | -15.41% | 6.46% | 26.16% | 15.44% | 17.99% | 31.27% | 8.16% | - | -27.96% | -65.7% | 77.54% | 100% | - | - |
| EBITDA | -79.53M | -69.15M | -53.55M | -54.43M | -30.56M | -74.35M | -46.17M | -43.74M | -35.85M | -34.93M | -39.97M | -46.78M | -48.79M | -41.57M | -48.99M | -68.38M | -53.19M | 0 | -40.16M | -41.45M |
| EBITDA Margin % | - | - | - | - | -203.73% | - | - | - | - | -509.73% | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -160.26% | 6.99% | -15.99% | -24.42% | 14.76% | -112.84% | -15.51% | 6.49% | 26.52% | 15.96% | 18.41% | 31.59% | 8.28% | - | -22.01% | -64.97% | 77.55% | 100% | - | - |
| D&A (Non-Cash Add-back) | 238.6K | -680K | 237K | 226K | 217K | 230K | 236K | 236K | 240K | 246K | 238K | 237K | 89K | 36K | 35K | 32K | 28K | 0 | 0 | 0 |
| EBIT | -79.64M | -87.31M | -51.84M | -46.68M | -21.86M | -107.8M | -39.4M | -40.59M | -35.04M | -33.12M | -38.93M | -46.49M | -47.69M | -41.67M | -52.09M | -63.03M | -52.92M | 0 | -40.16M | -41.45M |
| Net Interest Income | 2.4M | 1.68M | 875K | 1.5M | 5.01M | 2.37M | 783K | 715K | 62K | 363K | 412K | -391K | 186K | -2.16M | -1.84M | -1.63M | -1.4M | 0 | 65K | 27K |
| Interest Income | 5.14M | 4.49M | 3.77M | 4.38M | 7.89M | 4.84M | 3.34M | 3.24M | 2.59M | 2.93M | 2.95M | 2.06M | 2.53M | 0 | 77K | 25K | 104K | 0 | 65K | 27K |
| Interest Expense | 2.73M | 2.81M | 2.89M | 2.88M | 2.88M | 2.48M | 2.56M | 2.52M | 2.53M | 2.57M | 2.54M | 2.45M | 2.35M | 2.16M | 1.92M | 1.65M | 1.5M | 0 | 0 | 0 |
| Other Income/Expense | 1.38M | 1.79M | -935K | 5.09M | 6.04M | -35.7M | 4.45M | 869K | -1.48M | -515K | -1.26M | -1.92M | -1.16M | -2.23M | -4.99M | 3.73M | -1.2M | 0 | -1.84M | -164K |
| Pretax Income | -78.39M | -66.69M | -54.73M | -49.56M | -24.74M | -110.28M | -41.96M | -43.11M | -37.56M | -35.69M | -41.47M | -48.94M | -50.04M | -43.84M | -54.02M | -64.68M | -54.42M | 0 | -40.16M | -41.45M |
| Pretax Margin % | - | - | - | - | -164.92% | - | - | - | - | -520.84% | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 850K | -522K | 166K | 778K | 1.4M | 1.05M | 608K | 705K | 481K | 1.14M | -2.83M | -24.05M | 677K | -664K | -141K | -22K | 80K | 0 | 0 | 0 |
| Effective Tax Rate % | -1.08% | 0.78% | -0.3% | -1.57% | -5.65% | -0.95% | -1.45% | -1.64% | -1.28% | -3.21% | 6.81% | 49.15% | -1.35% | 1.51% | 0.26% | 0.03% | -0.15% | - | 0% | 0% |
| Net Income | -79.24M | -66.16M | -54.89M | -50.34M | -26.14M | -111.33M | -42.57M | -43.82M | -38.05M | -36.84M | -38.65M | -24.89M | -50.71M | -43.17M | -53.88M | -64.66M | -54.5M | 0 | -40.16M | -41.45M |
| Net Margin % | - | - | - | - | -174.23% | - | - | - | - | -537.53% | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -203.2% | 40.57% | -28.95% | -14.9% | 31.31% | -202.22% | -10.14% | -76.07% | 24.98% | 14.68% | 28.26% | 61.51% | 6.94% | - | -34.17% | -55.99% | 77.25% | 100% | - | - |
| Net Income (Continuing) | -79.24M | -66.16M | -54.89M | -50.34M | -26.14M | -111.33M | -42.57M | -43.82M | -38.05M | -36.84M | -38.65M | -24.89M | -50.71M | -43.17M | -53.88M | -64.66M | -54.5M | 0 | -40.16M | -41.45M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 | -0.84 | -0.37 | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 | -0.68 | -0.45 | -0.65 |
| EPS Growth % | -160% | 44.05% | -10.81% | 5% | 47.37% | -121.05% | 7.5% | -53.85% | 28.3% | 15.56% | 29.82% | 62.32% | 11.67% | 33.82% | -26.67% | -6.15% | 78.18% | -2100.65% | - | - |
| EPS (Basic) | -0.52 | -0.47 | -0.41 | -0.38 | -0.20 | -0.84 | -0.37 | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 | -0.69 | -0.60 | -0.68 | -0.45 | -0.65 |
| Diluted Shares Outstanding | 153.55M | 135.72M | 134.16M | 133.68M | 133.03M | 132.05M | 116.25M | 109.49M | 99.89M | 97.92M | 96.65M | 95.16M | 94.94M | 94.6M | 94.33M | 94.11M | 90.5M | 89.94M | 89.9M | 63.52M |
| Basic Shares Outstanding | 153.55M | 135.72M | 134.16M | 133.68M | 133.03M | 132.05M | 116.25M | 109.49M | 99.89M | 97.92M | 96.65M | 95.16M | 94.94M | 94.6M | 94.33M | 94.11M | 90.5M | 89.94M | 89.9M | 63.52M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |